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Background: The rapid spread of bacteria expressing multi-drug resistance propels the search for new antibacterial
agents. The present study was designed to evaluate the antibacterial activities of the methanol extracts from
Beilschmiedia obscura and six other Cameroonian plants against a panel of twenty nine Gram-negative bacteria
including Multi-drug resistant (MDR) phenotypes.
Methods: The phytochemical investigations of the extracts were carried out according to the standard methods
and the liquid micro-dilution assay was used for all antibacterial assays.
Results: Phytochemical analysis showed the presence of alkaloids in all studied extracts. Other chemical classes of
secondary metabolites such as anthocyanines, anthraquinones flavonoids, saponins, tannins, sterols and triterpenes were
selectively detected in the extracts. The extract from the fruits of Beilschmiedia obscura, Pachypodanthium staudtii leaves
and Peperomia fernandopoiana (whole plant) displayed the best spectrum of activity with MIC values ranging from 16 to
1024 μg/mL against at least 65% and above of the tested bacteria. The extract from Beilschmiedia obscura was the most
active with MIC values below 100 μg/mL against ten of the tested bacteria. This extract also showed MBC values below
1024 μg/mL against 55.17% of the studied microorganisms. Phenylalanine arginine β-naphthylamide (PAβN) significantly
modulated the activities of extracts from the leaves and fruits of Pachypodanthium staudtii and Beilschmiedia obscura
respectively, by increasing their inhibitory activity against Klebsiella pneumoniae KP55 strain at least four fold.
Conclusion: The overall results of the present investigation provide information for the possible use of the methanol
extracts of the studied plant species, especially B. obscura to fight infectious diseases caused by Gram-negative bacteria
including MDR phenotypes.
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Medicinal plantsBackground
Bacterial chemo-resistance is a worrisome health concern
worldwide today [1-3]. The development of multi-drug
resistant (MDR) bacteria has severely compromised the
efficacy of antimicrobial weapons and has dramatically in-
creased the frequency of therapeutic failure [4]. Several re-
ports highlighted the increased hospital dissemination of
the bacterial strains expressing drug efflux mechanism* Correspondence: kuetevictor@yahoo.fr
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unless otherwise stated.[5,6]. Among the known efflux mechanisms of resistances
in Gram-negative bacterial strains, Resistance-Nodulation-
cell Division (RND) pump is one of the most occurring
systems [7]. A number of chemicals such as phenylalanine
arginine β-naphthylamide (PAβN), 1-(1-naphthylmethyl)-
piperazine, some quinolone derivatives [8] as well as some
natural products like reserpine [9] have been found to
inhibit bacteria efflux pumps. The problem of bacterial
resistance to commonly used antibiotics then shifted at-
tention towards the discovery of new natural antibacterial
compounds. Plants commonly used as herbal medicinel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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activities [10-12]. In Cameroon, there is a rich tradition of
using medicinal plants for the treatment of various infec-
tious diseases, inflammations, injuries, and other diseases
[13,14]. The aim of the investigation was to determine the
antibacterial effects of twelve methanol crude extracts be-
longing to seven Cameroonian medicinal plants namely
Peperomia fernandopoiana C.DC. (Piperaceae); Cinchona
succirubia Par. Ex Klotzsk. (Rubiaceae), Pachypodanthium
staudtii Engl & Diels (Annonaceae), Vepris soyauxii Engl.
(Rutaceae), Crassocephalum biafrae (Oliv. & Hiern) S.
Moore; Beilschmiedia obscura (Staph). Engl. (Lauraceae)
and Entada gigas (Linn) Fawcelt & Rendle (Mimosaceae)
against a panel of MDR Gram-negative bacteria expressing
active efflux pumps. Most of these plant species or their
related genus are known for their antimicrobial properties
(Table 1). The role of efflux pumps was also investigated
using pump-deleted bacteria and the efflux pump inhibitor
(EPI) PAβN.
Methods
Plant materials and extraction
All medicinal plants used in the work were collected in dif-
ferent areas of Cameroon between January and April 2012.
The plants were identified at the National Herbarium
(Yaounde, Cameroon), where voucher specimens were de-
posited under the reference numbers (Table 1). The air-
dried and powdered plant material was weighed (300 g)
and soaked in 1 L of methanol (MeOH) for 48 h at room
temperature. The filtrate obtained through Whatman filter
paper No1was concentrated under reduced pressure in a
vacuum to obtain the crude extracts. All crude extracts
were kept at 4°C until further uses.
Preliminary phytochemical investigations
The plant extracts were screened for the presence of
major secondary metabolite classes such as alkaloids, an-
thocyanins, anthraquinones, flavonoids, phenols, saponins,
sterols and triterpenes according to common phytochem-
ical methods previously described by Harbone [38].
Chemicals
Chloramphenicol (CHL) (Sigma-Aldrich, St Quentin
Fallavier, France) was used as reference antibiotic (RA). p-
Iodonitrotetrazolium chloride (INT) and phenylalanine ar-
ginine β-naphthylamide (PAβN) (Sigma-Aldrich) were used
as bacteria growth indicator and efflux pumps inhibitor
(EPI) respectively.
Bacterial strains and culture media
MDR isolates (Laboratory collection) and reference strains
(from the American Type Culture Collection: Escherichia
coli ATCC8739 and ATCC10536; Enterobacter aerogenes
ATCC13048; Klebsiella pneumoniae ATCC11296; andProvidencia stuartii ATCC29916) of Escherichia coli, En-
terobacter aerogenes, Klebsiella pneumoniae, Enterobacter
cloacae, Pseudomonas aeruginosa, and Providencia stuar-
tii were used. Their features were previously reported
[39,40]. They were maintained at 4°C and sub-cultured on
a fresh appropriate Mueller Hinton Agar (MHA) for 24 h
before any antibacterial test.
Microdilution assay for MIC and MBC determinations
The microdilution inhibitory concentration (MIC) of the
seven plant extracts and chloramphenicol were determined
using a rapid microdilution assay [41,42]. Briefly, the
samples were first dissolved in 10% dimethyl sulfoxide
(DMSO)/Mueller Hinton Broth (MHB). The solution ob-
tained was then added to MHB and serially diluted two
fold (in a 96-well microplate). One hundred microliters of
inoculum (1.5 × 106 CFU/mL) prepared in MHB were then
added. The plates were covered with a sterile plate sealer
and then agitated with a shaker to mix the contents of the
wells and incubated at 37°C for 18 h. The final concentra-
tion of DMSO was less than 2.5%, and did not affect the
microbial growth. Wells containing MHB, 100 μl of inocu-
lum, and DMSO at a final concentration of 2.5% served as
the negative control. The MIC of each sample was detected
after 18 h of incubation at 37°C following addition of 40 μl
INT (0.2 mg/mL) and incubation at 37°C for 30 min. The
MIC was defined as the lowest sample concentration that
prevented color change of the medium and that resulted in
the complete inhibition of bacterial growth [43]. Viable
bacteria reduced the yellow dye to a pink. The minimum
bactericidal concentration (MBC) of the sample was deter-
mined by sub-culturing 50 μl of the suspensions from the
wells which did not show any growth after incubation dur-
ing MIC assays to 150 μl of fresh broth, and re-incubated
at 37°C for 48 hours before re-evaluation. The MBC was
defined as the lowest concentration of sample which com-
pletely inhibited the growth of bacteria [44,45]. Each assay
was performed in three independent tests in triplicate.
The tested samples, the samples were also tested in the
presence of PAβN at a final concentration of 20 μg/mL as
previously described [46] against nine of the most resistant
bacteria strains. The MIC was determined as described
above.
Results
Phytochemical composition of the plant extracts
The results of the qualitative phytochemical analysis in-
dicated that alkaloids were present in all plant extracts.
Each of the studied plant extract contained at least two
classes of secondary metabolites (Table 2).
Antibacterial activity of the plant extracts
The data depicted in Table 3 show that all extracts were
active on at least two bacterial strains with MIC values
Table 1 Plants used in the present study and evidence of their bioactivities
Samples, (family), and
herbarium numbera
Traditional treatment Area of plant
collection
Known bioactive (or potentially active)
compounds
Screened activity for crude plant extracts
and bioactive compounds
Vepris soyauxii Engl. (Rutaceae)
18394 SFR/Cam




Maculin, flindersiamin, skimmianin, (−)
ribalinin, (+)-isoplatydesinin and araliopsin
[17].
Stem bark extracts reduced sex hormones









Pachypodanthium staudtii Engl &
Diels (Annonaceae), 23170 SFR/
Cam
Chest pain, tumors [18]; toothache [19];




Pachypophyllin, pachypostaudins A and B
[21]; pachypodanthine [22]; Pachypophyllin
and pachysontol [23]; staudin [24]; Sabinene,
β -elemene, E- β -caryophyllene, β -selinene,
β -bisabolene, δ -cadinene, 2,4,5-trimethoxy-
1-vinylbenzene [25].
Hexane fraction protects legume seeds from
bruchid insects: Acanthoscelides obtectus Say
on common bean (Phaseolus vulgaris) and
Callosobruchus maculatus on cowpea (Vigna
unguiculata) [26].
The flavonoid Pachypodol or 3,7,3’-tri-O-
methylquercetin) showed antiviral activity
against the polio-virus [21,27].
Crassocephalum biafrae (Oliv. et
Hiern) S.Moore 43562 HNC
Diabetes, pulmonary defects ([28,29];
bleeding, sore eyes, cough, heart troubles,





Biafraecoumarins A, B, and C [33]. Biafraecoumarins A, B, and C exhibit low to
significant antimicrobial activities against E.
coli, B. subtilis, S. aureus, P. picketti, T.
longifusus, A.flavus, M.canis, F.solani, C.
albicans, and C.glabrata [33].
The evidence on the puberty onset
induction and ovarian folliculogenesis effect
of the aqueous extract in immature female
rat have been demonstrated [34].
Entada gigas (Linn) Fawcelt et
Rendle (Mimosaceae) 5861 SRF/
Cam
Microbial infections (Personal information) Foreke-Dschang, West
region of Cameroon
/ /
Cinchona succirubia Par. Ex Klotzsk.
(Rubiaceae) 25851 SRF/Cam
Malaria [35,36]. Foreke-Dschang, West
region of Cameroon
Quinine [36] Evident antiplasmodial activity against
chloroquine resistant Plasmodium falciparum
and a total chemosuppression of
parasitaemia in mice infected with

































Table 2 Extraction yields and phytochemical composition of the plant extracts





Alkaloids Anthocyanines Anthraquinones Flavonoids Phenols Saponins Tannins Sterols Triterpenes
Vepris soyauxii Leaves (6.17%), + + - + + + + + +
Stem bark
(8.58%)
+ + + + + + + - +
Root bark
(9.26%).










+ - - - - - - + -
Entada gigas Leaves (5.86%) + - - - + - + - -
Cinchona succirubia Leaves
(10.18%)
+ - - + + - + + -
Stem barks
(10.96%)
+ + + + + - + - -
Beilschmiedia
obscura
Fruits (3.37%) + + - - + + + - +
Pachypodanthium
staudtii
Leaves (10%) + + + - + - + + -
Stems bark
(9.4%)
+ + + + + - + + +
Root (6.25%). + + + + + + + - +
(+): present; (−): absent.
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tii leaves and P. fernandopoina (whole plant) displayed
the highest spectrum of activity, their inhibitory effects
being observed against 72.41% (21/29) of the bacterial
strains, followed by those from the fruits of B. obscura
(65.52%), stem barks of V. soyauxii, P. staudtii (55.17%),
P. staudtii stem bark and V. soyauxii leaves (51.72%).
The extract from B. obscura showed the best activity
with MIC values below 100 μg/mL recorded against ten
of the tested bacteria. The MIC values of this extract
were lower than those of choramphenicol against K.
pneumoniae Kp55 and E. aerogenes EA27 strains. Other
extracts exhibited weak activities against a limited num-
ber of strains studied. The Bactericidal activity of the
extracts was mostly noted with the extract from B.
obscura.Role of efflux pumps in susceptibility of Gram-negative
bacteria to the tested plant extracts
When combined, PAβN modulated significantly the activ-
ities (by decreasing the MIC values at least four times) of
the extract from P. staudtii leaves and B. obscura on K.
pneumoniae Kp55 strain. Therefore, PAβN in general had
little or no effects on the increase of the activities of the
tested plant extracts. It improved the activity of chloram-
phenicol on MDR bacteria used (Table 4).Discussion
Phytochemical composition of the plant extracts
The selective distribution of the secondary metabolites
in the plant extracts may be due to the difference in the
plant genus and family or the plant parts used. In fact,
the presence of a particular metabolite can be influenced
by the metabolisms which take place in the different
plant parts. Compounds belonging to alkaloids as well as
phenolics and terpenoids are well documented for their
antibacterial activities [11]. Their presence in the studied
extracts could therefore explain the observed activities.
Antibacterial activity of the plant extracts
Phytochemicals are routinely classified as antimicrobials on
the basis of susceptibility tests that produce MIC in the
range of 100 to 1000 μg/mL [47]. Moreover, for crude ex-
tract, antimicrobial activity is considered to be significant if
MIC values are below 100 μg/mL and moderate when 100 <
MIC < 625 μg/mL [11]. Therefore, the activity recorded
with B. obscura against ten of tested bacteria strains namely
E. coli (ATCC10536, AG8739, AG100, W3110), K. pneumo-
niae ATCC11296, KP63), E. aerogenes (ATCC13048, EA27
and EA294) and P. stuarti ATCC29916 can be considered
important. If we considered the alternative criteria de-
scribed by Fabry et al. [48], where extracts having MIC
values below 8000 μg/mL have noteworthy antimicrobial
activity, the overall activity recorded with most of the
Table 3 Minimal inhibitory concentration (MIC) and minimal bactericidal (MBC) of the plant extracts and chloramphenicol on the studied bacterial species
Bacterial strains Tested samples, MIC and MBC in parenthesis (μg/mL)
P. fernandopoina
(Whole plant)







Leaves Stem bark Leaves Stem bark Root Leaves Stem bark Root bark
E. coli
ATCC8739 256(−) 512(−) - 1024(1024) 1024(−) 1024(1024) - 256(512) 512(512) - 16(128) - 2(32)
ATCC10536 512(−) 1024(−) - 512(−) - 1024(−) 1024(−) 256(1024) 512(1024) 1024(−) 32(256) 1024(−) <2(32)
AG100 - 1024(−) 1024(−) 512(−) 1024(−) 512 (512) 1024(−) 1024(−) 1024(−) 64(512) - 16(128)
AG100A 512(−) 512(−) - 512(−) 1024(−) 512(−) 1024(−) - - 512(−) 128(512) 1024(−) <2(64)
AG100ATet 512(−) - - 1024(−) - 1024(−) 1024(−) 512(512) 1024(−) - 1024(1024) - 32(256)
AG102 1024(−) - 1024(−) 1024(−) 1024(−) - 1024(−) - - - 1024(−) 1024(−) 32(>256)
MC4100 1024(−) 512(−) - 128(1024) 1024(−) - 512(512) 512(1024) 256(1024) 512(−) 128(1024) 256(1024) 32(>256)
W3110 512 (1024) 1024(−) - - 1024(−) - 1024(−) 256(1024) 1024(−) 1024(−) 32(256) 512(−) 8(128)
E. aerogenes
ATCC13048 -(−) 1024(−) - 512 (1024) 1024(−) - - 1024(−) - - 32(256) 1024(−) 8(64)
CM64 1024(−) - - - - - - - - - - - >256
EA27 1024(−) - - 1024(−) 1024(−) 512(−) 1024(−) 1024(−) 1024(−) - 32(512) - 64(256)
EA3 1024(−) 1024(−) - 1024(−) - 512(−) - - 512(−) 1024(−) - 1024(−) 128(>256)
EA289 - - - 1024(−) - - - - - - - - 128(>256)
EA298 1024(−) - - 1024(−) - - - - - - - - 128(>256)
EA294 512(−) 1024(−) - 256(512) 1024(1024) 1024(1024) 512(1024) 512(−) - - 64(−) - 16(64)
E. cloacae
ECCI69 1024(−) - - - - - - - - - - - >256
BM47 - - - - - - - - - - - - >256
BM67 - - - - - - - - - - - 1024(−) >256
K. pneumoniae
ATCC11296 256(1024) 1024(−) - 256(1024) 512(−) 1024(1024) 1024(−) 256 (1024) 512 (1024) - 64(256) 1024(−) 4(64)
KP55 512(512) - - 512 (1024) 1024(−) 512(−) 1024(1024) 1024(1024) 512(1024) 1024(−) 32(128) - 64(256)
KP63 512(−) 1024(−) - 1024(−) - 1024(−) 1024(−) 1024(−) - 1024(−) 512(1024) - 64(256)
K24 1024(−) - - - - - - - - - - - 32(256)
























Table 3 Minimal inhibitory concentration (MIC) and minimal bactericidal (MBC) of the plant extracts and chloramphenicol on the studied bacterial species
(Continued)
P. stuartuii
ATCC29916 1024(−) 1024(−) - 1024(−) 1024(−) 512(−) 1024(−) 512(−) 512(−) 512(−) 64(256) 512(512) 16(128)
NEA16 - - - - - - - - - - - - 64(256)
PS2636 1024 1024(−) - 256(1024) 512(−) 512(−) 1024(−) 128(1024) 512(−) 1024(−) 128(512) - 32(256)
PS299645 - 1024(−) - 1024(−) 1024(−) 512(−) - 512(−) 512(−) 1024(−) 128(512) - 32(256)
P. aeruginosa
PA01 1024(−) - - 1024(−) - 1024(1024) - 1024(−) - - 1024(−) 512(−) 32(256)
PA124 - - - - - - - - - - - - 64(>256)
























Table 4 MIC of tested plant extracts in the absence and presence of PAβN against the studied bacterial strains
Bacterial
strains
Tested samples and MIC (μg/mL)
P. Fernandopoina
(Whole plant)







Leaves S. bark Leaves S. bark Root Leaves S. bark R. bark
E. coli
AG100ATet 1024 (512) - (−) - (−) 1024 (−) - (−) 1024 (1024) 1024 (1024) 512 (1024) 1024 (1024) - (−) 1024 (1024) - (−) 64 (≤2)
AG102 1024 (1024) - (−) - (−) 1024 (1024) - (1024) - (−) 1024 (1024) - (1024) - (−) - (−) 1024 (1024) 1024 (1024) 32 (≤2)
E. aerogenes
CM64 - (−) - (−) - (1024) - (−) - (−) - (−) - (−) - (−) - (−) - (−) - (−) - (−) >256 (16)
EA289 - (−) - (−) - (−) 1024 (−) - (−) - (−) - (−) - (1024) - (−) - (−) - (−) - (1024) 128 (16)
E. cloacae
ECCI69 1024 (1024) - (1024) - (512) - (−) - (−) - (−) - (−) - (−) - (1024) - (−) - (−) - (−) >256 (128)
K. pneumonia
KP55 512 (512) - (−) - (−) 512 (128) 1024 (512) 512 (256) 1024 (1024) 1024 (1024) 512 (512) 1024 (−) 32 (≤8) - (−) 64 (4)
K24 1024 (1024) - (−) - (1024) - (−) - (−) - (−) - (−) - (−) - (−) - (−) - (−) - (−) 32 (2)
P. stuartuii
NEA16 - (−) - (−) - (−) - (1024) - (−) - (−) - (−) - (−) - (−) - (−) - (−) - (−) 64 (4)
P. aeruginosa
PA124 - (−) - (−) - (−) - (−) - (−) - (−) - (−) - (−) - (−) - (−) - (−) - (−) 64 (8)
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http://www.biomedcentral.com/1472-6882/14/241studied extracts can be considered important, notably the
extracts from P. fernandopoina, B. obscura, V. soyauxii and
P. staudtii leaves. When analysing the MIC and MBC re-
sults for the crude extract, MBC/MIC ratios lower than 4
were noted with most of the studied samples, suggesting
that their killing effects could be expected. Therefore, the
extract from B. obscura displayed in many cases, a bacterio-
static effect (MBC/MIC > 4) [49]. To the best of our know-
ledge, the antibacterial activity of the plant extracts used is
being reported herein for the first time, particularly towards
MDR bacteria. Nevertheless, the antimicrobial potentials
of the related genus for the most active plants have been
demonstrated, particularly those of genus Beilschmiedia.
Chouna et al. [50] demonstrated that compounds like
beilschmiedic acid C from B. anacardioides were signifi-
cantly active against Bacillus subtilis, Micrococcus luteus
and Streptococcus faecalis. Beilschmiedia cinnamomea was
previously demonstrated to have significant to moderate
activities (64–1024 μg/mL) against the tested MDR bac-
teria [39]. Some compounds previously isolated from the
genus Beilschmiedia and belonging to alkaloids, phe-
nols, saponines, sterols and triterpenoids [50-52] were
reported to possess antimicrobial activities [53]. The genus
Beilschmiedia is also known traditionally to possess anti-
microbial activities [53]. The fruits of B. obscura used
herein are also used as soup ingredient in Cameroun [54].
This highlights its importance in the control of microbial
infections and mostly those involving MDR phenotypes.
Compounds belonging to alkaloids, flavonoids, sterols and
triterpenoids classes previously isolated from P. staudtii
[21-25] may be responsible for their observed activities.
Bioactive alkaloids like araliopsin were previously isolated
from V. soyauxii [17].
To assess the implication of efflux pumps in the suscep-
tibility of Gram-negative bacteria to the tested plant ex-
tracts, PAβN a potent inhibitor of RND efflux systems and
particularly active on AcrAB–TolC (of Enterobaceriaceae)
and MexAB–OprM (of Pseudomonas species) [8,55] has
been used at a concentration of 20 μg/mL. This concen-
tration had no intrinsic effect on the bacteria as previously
determined [46,56]. A significant increase of the anti-
bacterial activities of the extract from P. staudtii and B.
obscura was observed against resistant bacteria K. pneu-
moniae Kp55 strain, showing that one or more active
compounds present in these plant extracts could be sub-
strate(s) of efflux pumps of this bacteria. However, little or
no increase of activities observed with the remaining ex-
tracts in the presence of EPI may be an indication that ei-
ther secondary metabolites of these extracts are not active
against the studied bacteria or that RND efflux pumps are
not the main resistance mechanisms involved. The tested
bacteria are good models in investigating MDR as they
expressed active efflux pumps as observed when choram-
phenicol was tested in the presence of PAβN.Conclusions
The investigation provided informative data for the use of
the crude medicinal plant extracts tested, especially those
from Beilschmiedia obscura, Peperomia fernandopoiana
and Pachypodanthium staudtii in the fight against MDR
bacteria. The isolation of active constituents from these
plants will further be performed in order to identify their
active antibacterial ingredients.
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